The mission of the Scleroderma Research Foundation is to fund and facilitate the most promising, highest quality research aimed at new treatments and, ultimately, a cure for scleroderma.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$33.0M
+76.9% YoY
Annual Giving
$3.3M
+33.6% YoY
Grant Count
23
+4.5% YoY
Avg Grant Size
$144K
+27.8% YoY
About Scleroderma Research Foundation
Based on IRS filings
Scleroderma Research Foundation is a nonprofit organization focused on Medical Research, based in SAN FRANCISCO, CA. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $33.0M in total assets. In 2024, it awarded 23 grants totaling $3.3M. Net investment income was $1.2M.
Focus Areas
Ready to take the next step with Scleroderma Research Foundation?
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $32,999,784 | $18,654,748 | $11,143,637 |
| Revenue | $12,173,161 | $8,418,038 | $5,892,738 |
| Expenses | $9,622,521 | $6,487,599 | $4,658,602 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $1,211,667 | $904,546 | $116,754 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
98 grants across all recorded years
Open Grants
3 open opportunities from Scleroderma Research Foundation
Early Career Grants
Scleroderma Research Foundation
Amount
Varies
Deadline
December 31, 2027
Established Investigator and New Faculty Grants
Scleroderma Research Foundation
Amount
Varies
Deadline
December 31, 2027
Postdoctoral Fellowship Grants
Scleroderma Research Foundation
Amount
Varies
Deadline
December 31, 2027
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| Gregory Gordon | Chief Medical Officer | 40 | $416,000 |
| Joanne Gold | Executive Dir. | 40 | $215,900 |
| Gloria Blecha | VP Communications | 40 | $171,600 |
| Kate Ceredona | Dir. Philanthropy | 40 | $152,258 |
| Hannah Young | Dir. Communication | 40 | $130,007 |
| Luke Evnin PhD | Chairman | 30 | — |
| Susan Feniger | Secretary | 10 | — |
| Deann Wright | Treasurer | 10 | — |
| Omar Baker MD | Board Member | 2 | — |
| Sharon Dobie MD | Board Member | 2 | — |
| Eric Kau MD | Board Member | 2 | — |
| David Knoller | Board Member | 1 | — |
| Violetta Merin | Board Member | 2 | — |
| Regina Hall | Board Member | 2 | — |
| Jeff Seaman | Board Member | 2 | — |
Subject Areas
Focus areas based on grantmaking activity
Data last updated April 2026. Sourced from IRS Form 990-PF filings.
What could you do with Scleroderma Research Foundation on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities